Typical Atrial Flutter as a Risk Factor for the Development of Atrial Fibrillation in Patients Without Otherwise Demonstrable Atrial Tachyarrhythmias

Ng, Daniel W. C.; Altemose, Gregory T.; Qing Wu; Srivathsan, Komandoor; Scott, Luis R. P.
June 2008
Mayo Clinic Proceedings;Jun2008, Vol. 83 Issue 6, p646
Academic Journal
OBJECTIVE: To investigate the incidence of atrial fibrillation after successful radiofrequency ablation for typical atrial flutter (AFL) and to compare its incidence with that of a reference population from the Framingham Heart Study to determine whether atrial flutter is an independent predictor for development of atrial fibrillation. PATIENTS AND METHODS: Medical records of 234 patients who underwent radiofrequency ablation for AFL between January 1, 2002, and June 30, 2006, were reviewed. Patients were excluded if they had a history of atrial fibrillation or sustained atrial arrhythmia other than AFL or if they had atrial tachyarrhythmias other than AFL that could be induced during electrophysiology study (133 total patients excluded). The remaining 101 patients who underwent successful radiofrequency ablation for AFL were monitored for new-onset atrial fibrillation. RESULTS: During the mean±SD follow-up period of 574±315 days, atrial fibrillation developed in 13 (12.9%) of 101 patients. Atrial fibrillation developed in 12 of these patients within 6 months of ablation. The cumulative event-free rates (95% confidence intervals) were 97% (94%-100%) at 1 month, 91% (87%-97%) at 3 months, and 86% (81%-94%) at 6 months. Compared with the general population, patients aged 50 to 79 years who had ablation had a significantly higher incidence of atrial fibrillation (50-59 years, P=.01; 60-69 years, P=.001; 70-79 years, P=.007). CONCLUSION: Our finding of atrial fibrillation in 12.9% of patients whose atrial flutter was successfully eradicated suggests that patients with atrial flutter are at increased risk of developing atrial fibrillation, especially within the first 6 months after ablation.


Related Articles

  • Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What Might Be Their Implications for Arrhythmia Control?  // Journal of Cardiovascular Pharmacology & Therapeutics;Jul2002, Vol. 7 Issue 3, p131 

    This article focuses on atrial fibrillation following investigation of rhythm management. During the last decade or so, major changes have been made in the approaches to the control of supraventricular as well as ventricular tachyarrhythmias. Atrial fibrillation is the most common cardiac...

  • Antiarrhythmic Drugs in Patients with Implantable Cardioverter-Defibrillators. Bollmann, Andreas; Husser, Daniela; Cannom, David S. // American Journal of Cardiovascular Drugs;2005, Vol. 5 Issue 6, p371 

    Antiarrhythmic drugs need to be initiated in up to 70% of patients with implantable cardioverter-defibrillators (ICDs) in order to treat atrial tachyarrhythmias, decrease the frequency of defibrillator shocks, and terminate ventricular arrhythmias along with antitachycardia pacing. Atrial...

  • An index for evaluating distance of a healthy heart from Sino-Atrial blocking arrhythmia. Gholizade-Narm, Hossein; Khademi, Morteza; Azemi, Asad; Karimi-Ghartemani, Masoud // Journal of Biomedical Science & Engineering;Mar2010, Vol. 3 Issue 3, p308 

    In this paper, an index for evaluating Distance of a healthy heart from Sino-Atrial Blocking Arrhythmia (SABA) is presented. After definition of the main pacemakers' model of heart, Sino-Atrial (SA) and Atrio-Ventricular nodes (AV), the boundary of synchronization, which demonstrates the...

  • Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation. Yokokawa, Miki; Oral, Hakan // JAFIB: Journal of Atrial Fibrillation;Oct/Nov2012, Vol. 5 Issue 3, p128 

    Radiofrequency catheter ablation that targets the pulmonary veins is well established as a mainstay for drug-refractory, paroxysmal atrial fibrillation (AF). However, in patients with persistent AF, the ideal approach remains elusive. Further, despite the various additional ablation strategies...

  • Transient ST-Segment Elevation during Transseptal Catheterization. Le, Bao H.; Black, James N.; Huang, Shoei K. Stephen // Texas Heart Institute Journal;2010, Vol. 37 Issue 6, p717 

    For the treatment of refractory left atrial tachyarrhythmias, including atrial fibrillation, transseptal catheterization is often performed in order to achieve pulmonary vein isolation and left atrial substrate ablation. Herein, we report an unexpected ST-segment elevation in a 71-year-old man...

  • Atrial Arrhythmias after Cardiothoracic Surgery. Ommen, Steve R.; Odell, John A.; Stanton, Marshall S. // New England Journal of Medicine;05/15/97, Vol. 336 Issue 20, p1429 

    Presents a study of the clinical and therapeutic implications of postoperative atrial tachyarrhythmias, such as atrial fibrillation, flutter and tachycardia. Postoperative atrial tachyarrhythmias as a possible result of pericardial inflammation and autonomic imbalance of the early postoperative...

  • Operative Technique and Atrial Tachyarrhythmias After Orthotopic Heart Transplantation. Sattiraju, Srinivasan; Vats, Shashank; Krishnan, Balaji; Kim, Sun K.; Austin, Erin; Can, Ilknur; Tholakanahalli, Venkatakrishna; Benditt, David G.; Chen, Lin Y. // JAFIB: Journal of Atrial Fibrillation;Dec2012/Jan2013, Vol. 5 Issue 4, p31 

    There is conflicting evidence that operative technique affects the risk of atrial tachyarrhythmia after orthotopic heart transplantation (OHT). We sought to determine whether OHT by bicaval (BC) technique is associated with a lower risk of atrial tachyarrhythmia than biatrial (BA) technique....

  • Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Wirth, Klaus J.; Knobloch, Karsten // Naunyn-Schmiedeberg's Archives of Pharmacology;Feb2001, Vol. 363 Issue 2, p166 

    Objectives: Antiarrhythmic drugs have been shown to prolong right atrial refractoriness while data on the left atrium are not available. In pigs we have observed shorter effective refractory periods (ERP) of the left compared with the right atrium associated with a much higher left atrial...

  • Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Hidalgo, J. D.; Krone, R.; Rich, M. W; Blum, K.; Adkins, D.; Fan, M.-Y.; Brown, R.; Devine, S.; Graubert, T.; Blum, W.; Tomasson, M.; Goodnough, L. T.; Vij, R.; DiPersio, J.; Khoury, H. // Bone Marrow Transplantation;Oct2004, Vol. 34 Issue 7, p615 

    Summary:Recent studies suggest that cancer patients may be at increased risk for supraventricular tachyarrhythmias (SVTA). We have observed clinically significant SVTA in patients undergoing hematopoietic stem cell transplantation occurring at a median of 6 days post transplant, manifesting as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics